More NSCLC Updates (Checkmate-9La & ALTA-1L)
May 28, 2020•11 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Another week, another two new approved indications in NSCLC. We cover Checkmate-9La (Nivo/Ipi + 2 cycles of chemo) and ALTA-1L (1st Line brigatinib in ALK-rearranged NSCLC).
Finally, we cover an interesting case report highlighting the need to determine CNS penetration of kinase inhibitors.
(Lots of ASCO talk *next* week!)
For the best experience, listen in Metacast app for iOS or Android